A Prospective Comparative Study on Serum Acid Phosphatases in the Diagnostics of Prostatic Cancer
- 1 January 1985
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Urology and Nephrology
- Vol. 19 (4) , 247-251
- https://doi.org/10.3109/00365598509180264
Abstract
The diagnostic efficacy of two prostatic tumor markers, S-AP and S-PAP, was compared in a prospective clinical series consisting of 101 BPH- and 39 PCa-patients. As a predictor of prostatic cancer the specificity of S-AP (≥12 U/l) and S-PAP-RIA (≥4 μg/l) was 0.97 and 0.96, and the sensitivity 0.21 and 0.41, respectively. The S-PAP-RIA value of over 8 μg/l always predicted an inoperable prostatic cancer (T4 or M1). The authors conclude that neither of these enzymes is suitable for the screening of early prostatic cancer, but the S-PAP-RIA might be a good predictor of inoperability of advanced prostatic cancer.This publication has 10 references indexed in Scilit:
- Carcinoma of the Prostate: Current Thoughts on Diagnosis and StagingSurgical Clinics of North America, 1982
- Will Prostatic Acid Phosphatase Determination by Radioimmunoassay Increase The Diagnosis of Early Prostatic Cancer?Journal of Urology, 1981
- The Significance of Prostatic Acid Phosphatase in Adenocarcinoma of the ProstateJournal of Urology, 1981
- THE EFFECT OF MANIPULATION OF THE PROSTATE-GLAND ON SERUM PROSTATE-SPECIFIC ACID-PHOSPHATASE MEASURED BY RADIOIMMUNOASSAY1981
- Rapid radioimmunoassay for prostate-specific acid phosphatase in human serum.Clinical Chemistry, 1980
- The detection of prostatic cancer by radioimmunoassay: A review*Human Pathology, 1978
- The Detection of Prostatic Acid Phosphatase by Antibody Reactions in Gel DiffusionThe Journal of Immunology, 1964